Cargando…

Association of a novel endometrial cancer biomarker panel with prognostic risk, platinum insensitivity, and targetable therapeutic options

During the past decade, the age-adjusted mortality rate for endometrial cancer (EC) increased 1.9% annually with TP53 mutant (TP53-mu) EC disproportionally represented in advanced disease and deaths. Therefore, we aimed to assess pivotal molecular parameters that differentiate clinical outcomes in h...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bosquet, Jesus Gonzalez, Zhang, Qing, Cliby, William A., Bakkum-Gamez, Jamie N., Cen, Ling, Dowdy, Sean C., Sherman, Mark E., Weroha, S. John, Clayton, Amy C., Kipp, Benjamin R., Halling, Kevin C., Couch, Fergus J., Podratz, Karl C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840025/ https://www.ncbi.nlm.nih.gov/pubmed/33503056 http://dx.doi.org/10.1371/journal.pone.0245664

Ejemplares similares

ECPPF (E2F1, CCNA2, POLE, PPP2R1A, FBXW7) stratification: Profiling high-risk subtypes of histomorphologically low-risk and treatment-insensitive endometrioid endometrial cancer
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2022)

Prognostic stratification of endometrial cancers with high microsatellite instability or no specific molecular profile
por: Gonzalez-Bosquet, Jesus, et al.
Publicado: (2023)

Preserving fertility in young patients with endometrial cancer: current perspectives
por: Kalogera, Eleftheria, et al.
Publicado: (2014)

Pancreaticoduodenectomy in optimal primary cytoreduction of epithelial ovarian cancer: A case report and review of the literature
por: Beissel, Joy M., et al.
Publicado: (2014)

Disparities and interventions in the timeliness of endometrial cancer diagnosis and treatment in the United States: a scoping review protocol
por: Najor, Anna J., et al.
Publicado: (2021)

Disparities in Timeliness of Endometrial Cancer Care: A Scoping Review
por: Najor, Anna, et al.
Publicado: (2023)

Abdominopelvic inflammatory myofibroblastic tumor that metastasized to the vertebrae and liver: A case report and review of the literature
por: Kim, Sharon, et al.
Publicado: (2015)

Microarray Analysis on Gene Regulation by Estrogen, Progesterone and Tamoxifen in Human Endometrial Stromal Cells
por: Ren, Chun-E, et al.
Publicado: (2015)

HE4 (WFDC2) Promotes Tumor Growth in Endometrial Cancer Cell Lines
por: Li, Jinping, et al.
Publicado: (2013)

HE4 Transcription- and Splice Variants-Specific Expression in Endometrial Cancer and Correlation with Patient Survival
por: Jiang, Shi-Wen, et al.
Publicado: (2013)

Investigation of factors affecting the efficacy of 3C23K, a human monoclonal antibody targeting MISIIR
por: Gill, Sarah E., et al.
Publicado: (2017)

Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer
por: Barney, Brandon M, et al.
Publicado: (2013)

Decorative power generating panels creating angle insensitive transmissive colors
por: Lee, Jae Yong, et al.
Publicado: (2014)

Metronomic chemotherapy in platinum-insensitive failures and/or early failures postmultimodality management in oral cancers
por: Patil, Vijay M., et al.
Publicado: (2015)

HER2 gene amplification and EGFR expression in a large cohort of surgically staged patients with nonendometrioid (type II) endometrial cancer
por: Konecny, G E, et al.
Publicado: (2009)

Development of novel home-based tampon sampling for endometrial cancer: findings from community-based focus groups with Black and White women
por: Ridgeway, Jennifer L., et al.
Publicado: (2021)

LY2157299 Monohydrate, a TGF-βR1 Inhibitor, Suppresses Tumor Growth and Ascites Development in Ovarian Cancer
por: Zhang, Qing, et al.
Publicado: (2018)

Workshop on Program Options in Intermediate-Energy Physics : Summary and Panel Reports
por: Allred, John C, et al.
Publicado: (1980)

Induction of NEDD8-conjugating enzyme E2 UBE2F by platinum protects lung cancer cells from apoptosis and confers to platinum-insensitivity
por: Zhou, Lisha, et al.
Publicado: (2020)

Therapeutic options for management of endometrial hyperplasia
por: Chandra, Vishal, et al.
Publicado: (2016)

Tao brush endometrial cytology is a sensitive diagnostic tool for cancer and hyperplasia among women presenting to clinic with abnormal uterine bleeding
por: DeJong, Stephanie R., et al.
Publicado: (2021)

Acquisition of platinum drug resistance and platinum cross resistance patterns in a panel of human ovarian carcinoma xenografts.
por: Jones, M., et al.
Publicado: (1993)

The challenges of androgen insensitivity syndrome
por: Ovidiu, Bratu, et al.
Publicado: (2021)

DNA barcoded competitive clone-initiating cell analysis reveals novel features of metastatic growth in a cancer xenograft model
por: Aalam, Syed Mohammed Musheer, et al.
Publicado: (2022)

Leiomyoma with KAT6B-KANSL1 fusion: case report of a rapidly enlarging uterine mass in a postmenopausal woman
por: Ainsworth, Alessandra J., et al.
Publicado: (2019)

A cognitive pathway to punishment insensitivity
por: Jean-Richard-dit-Bressel, Philip, et al.
Publicado: (2023)

Activity of lapatinib a novel HER2 and EGFR dual kinase inhibitor in human endometrial cancer cells
por: Konecny, G E, et al.
Publicado: (2008)

Germline multigene panel testing of patients with endometrial cancer
por: Kral, Jan, et al.
Publicado: (2023)

Porphyromonas somerae Invasion of Endometrial Cancer Cells
por: Crooks, Taylor A., et al.
Publicado: (2021)

RNA‐seq and ATAC‐seq analysis of CD163 (+) macrophage‐induced progestin‐insensitive endometrial cancer cells
por: Wang, Lulu, et al.
Publicado: (2022)

When Failure Is Not an Option: The Independent Panel Pandemic Report
por: Adashi, Eli Y., et al.
Publicado: (2022)

Identification of potential models for predicting progestin insensitivity in patients with endometrial atypical hyperplasia and endometrioid endometrial cancer based on ATAC-Seq and RNA-Seq integrated analysis
por: Hu, Jia-Li, et al.
Publicado: (2022)

Targeted deep sequencing of mucinous ovarian tumors reveals multiple overlapping RAS-pathway activating mutations in borderline and cancerous neoplasms
por: Mackenzie, Robertson, et al.
Publicado: (2015)

Overcoming platinum resistance in ovarian cancer by targeting pregnancy-associated plasma protein-A
por: Torres, Diogo, et al.
Publicado: (2019)

Congenital insensitivity to pain with anhidrosis: a case report.
por: Kim, J. S., et al.
Publicado: (1999)

Mutation prevalence tables for hereditary cancer derived from multigene panel testing
por: Hart, Steven N., et al.
Publicado: (2020)

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic
por: Hendrickson, Andrea Wahner, et al.
Publicado: (2015)

Male breast cancer in a multi-gene panel testing cohort: insights and unexpected results
por: Pritzlaff, Mary, et al.
Publicado: (2016)

Emerging Treatment Options for Advanced or Recurrent Endometrial Cancer
por: Halla, Kimberly
Publicado: (2022)

Recurrent Endometrial Cancer: Local and Systemic Treatment Options
por: Rütten, Heidi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_s042ioulq8hdtd3r4a1c4emqhq